KoreaMed, a service of the Korean Association of Medical Journal Editors (KAMJE), provides access to articles published in Korean medical, dental, nursing, nutrition and veterinary journals. KoreaMed records include links to full-text content in Synapse and publisher web sites.
Korean Nationwide Surveillance of Antimicrobial Resistance in 2000 with Special Reference to Vancomycin Resistance in Enterococci, and Expanded-Spectrum Cephalosporin and Imipenem Resistance in Gram-Negative Bacilli
1Department of Laboratory Medicine and Research Institute of Bacterial Resistance, Yonsei University College of Medicine, Seoul, Korea. leekcp@yumc.yonsei.ac.kr
2Department of Laboratory Medicine, Dongguk University College of Medicine, Pohang, Korea.
3Department of Laboratory Medicine, Hallym University College of Medicine, Chunchon, Korea.
4Department of Laboratory Medicine, College of Medicine, Hanyang University, Kuri, Korea.
5Department of Laboratory Medicine, Seoul National University College of Medicine, Seoul, Korea.
6Department of Laboratory Medicine, College of Medicine, Hanyang University, Seoul, Korea.
Antimicrobial resistance surveillance is necessary to determine the size of the problem and to guide empirical selection of antimicrobial agents for treating infected patients. The aim of this study was to analyze the results of susceptibility tests performed by hospitals participating in the Korean Nationwide Surveillance of Antimicrobial Resistance (KONSAR) program. The rates of oxacillin-resistant staphylococci, penicillin-nonsusceptible pneumococci, and ampicillin-resistant E. faecium were over 70%. Ampicillin-resistant H. influenzae increased to 68%. Expanded-spectrum cephalosporin-resistant K. pneumoniae, fluoroquinolone-resistant E. coli, and imipenem-resistant P. aeruginosa remained at 16% through 27%, depending on the species. The proportions of vancomycin-resistant E. faecium and imipenem-resistant P. aeruginosa were 18 - 24% and 19-21%, respectively, indicating the seriousness of antimicrobial resistance. In conclusion, the increasing prevalence of resistant bacteria indicates that more concerted effort is required to conserve the usefulness of precious new antimicrobial agents.